EM-1032

N/A

Report date: 2025/09/03 17:58:29

Base Information

Drug NameEM-1032
Drug Alias NameEM1032
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionAnti-CD3Alkaline Phosphatase, Placental Like 2 inhibitors
TargetsT cell surface glycoprotein CD3Alkaline Phosphatase, Placental Like 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEpimab Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpimab Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A